Study guide
10.1 Skin and Mucous Membrane Symptoms
Certified Hospice and Palliative Nurse CHPN
Track your progress as you read
Finished sections get a check mark.
1 Introduction & Exam Overview
1.1 Current Exam Facts 1.2 Eligibility, Fees, Windows, and Retakes 1.3 Scoring, Test-Day Rules, and Remote Proctoring 1.4 Recertification: HPAR and the Situational Judgment Exercise
2 Chapter 2: Assessment, Goals, and Care Planning
2.1 Goals of Care and Shared Decision Making 2.2 Interdisciplinary Care Planning and Ongoing Evaluation 2.3 Prognostic and Functional Assessment Tools 2.4 Levels of Care and Care-Setting Transitions
3 Chapter 3: Life-Limiting Disease Progression I
3.1 Cancer, Hematologic, and Paraneoplastic Complications 3.2 Heart Failure and Cardiac Disease Progression 3.3 Pulmonary Disease Progression 3.4 Neurologic Disease Progression
4 Chapter 4: Disease Progression II and Imminent Death
4.1 Dementia, Frailty, and Feeding Decisions 4.2 Renal, Hepatic, and Endocrine Trajectories 4.3 Indicators of Imminent Death
5 Chapter 5: Pain Assessment
5.1 Pain Types, Etiology, and Syndromes 5.2 Verbal and Nonverbal Pain Assessment and Scales 5.3 Factors That Influence the Pain Experience
6 Chapter 6: Pharmacologic Pain Management
6.1 Opioid and Non-Opioid Analgesics by Pain Type and Severity 6.2 Adjuvant Analgesics 6.3 Titration, Baseline Dosing, and Breakthrough Pain 6.4 Equianalgesic Conversion and Route Changes
7 Chapter 7: Nonpharmacologic Pain and Opioid Safety
7.1 Nonpharmacologic Pain Interventions 7.2 Complementary and Integrative Pain Therapies 7.3 Opioid Adverse Effects, Neurotoxicity, and Rotation
8 Chapter 8: Neurological, Cardiovascular, and Respiratory Symptoms
8.1 Neurological Symptoms 8.2 Delirium and Terminal Restlessness 8.3 Cardiovascular Symptoms 8.4 Respiratory Symptoms: Dyspnea, Cough, and Secretions
9 Chapter 9: Gastrointestinal, Genitourinary, and Musculoskeletal Symptoms
9.1 Gastrointestinal Symptoms 9.2 Genitourinary Symptoms 9.3 Musculoskeletal Symptoms
10 Chapter 10: Skin, Metabolic, Hematologic, and Psychospiritual Symptoms
10.1 Skin and Mucous Membrane Symptoms 10.2 Nutritional and Metabolic Symptoms 10.3 Immune and Hematologic Symptoms 10.4 Psychosocial, Emotional, and Spiritual Symptom Burden
11 Chapter 11: Advance Care Planning, Benefits, and Safety
11.1 Advance Care Planning and Life-Sustaining Therapies 11.2 Hospice and Palliative Benefits under Medicare, Medicaid, and Private Insurance 11.3 Patient Safety: Environmental, Physical, and Socioemotional
12 Chapter 12: Communication, Culture, and Psychosocial Support
12.1 Communication Techniques, Barriers, and Family Meetings 12.2 Cultural Humility and Spiritual Needs 12.3 Psychosocial Needs and IDG Participation
13 Chapter 13: Caregiver Education and Medication Management
13.1 Medication Management and Controlled Substances 13.2 Caregiver and Family Self-Care 13.3 Teaching End-Stage Disease, Pain, and Symptom Plans 13.4 Caregiver Skills, DME, Supplies, and Services
14 Chapter 14: Grief, Death, and End-of-Life Ethics
14.1 Grief, Loss, and Bereavement 14.2 Support at the Time of Death and Post-Mortem Care 14.3 Ethical Issues Related to End of Life
15 Chapter 15: Medicare Hospice Compliance and National Standards
15.1 Medicare Hospice Benefit and Conditions of Participation 15.2 Hospice Eligibility, Admission, and Recertification 15.3 National Hospice and Palliative Care Standards 15.4 National Consensus Project Clinical Practice Guidelines
16 Chapter 16: Legal, Professional Practice, Quality, and Policy
16.1 Legal Regulations: CMS, HIPAA, and OSHA 16.2 Professional Boundaries and Ethics 16.3 QAPI, Self-Care, and Precepting 16.4 Policy, Delivery, and Reimbursement Trends
10.1 Skin and Mucous Membrane Symptoms
Key Takeaways Explain This Topic AI
A Kennedy terminal ulcer is sudden terminal ulceration (often pear- or butterfly-shaped over the sacrum) and is not automatically a quality failure when prevention was appropriate.
NPIAP staging names depth; never reverse-stage a healing full-thickness wound, and do not call moisture-associated damage a stage 2 pressure injury by default.
Malignant fungating wounds are usually managed to contain odor, exudate, bleeding, and appearance; topical metronidazole and charcoal dressings are first-line odor tools.
Xerostomia needs alcohol-free mouth care; candidiasis is treated with nystatin for limited oral disease and fluconazole when disease is extensive or esophageal; pruritus is treated by mechanism, not with antihistamines alone.
Last updated: August 2026
Why this cluster scores on CHPN
Certified Hospice and Palliative Nurse (CHPN) Domain 3 — Patient Care: Symptom Management — includes skin, mucous membrane, nutritional, hematologic, and psychospiritual symptoms alongside the better-known dyspnea and nausea items. HPCC scores the exam on a 200 to 800 scale with 500 as the passing scaled score; this chapter will not make that cut by itself, but these stems are easy points if you practice goal selection . The exam is less interested in whether you can recite a poster of stages and more interested in whether you will chase closure of a dying wound, treat thrush, or wrongly treat a terminal ulcer as a survey failure.
Families often hear skin breakdown as neglect. The correct CHPN move is to distinguish preventable pressure injury from terminal skin failure , and healable tissue from containment of odor, exudate, pain, and bleeding.
Pressure injury: stage what you see
Use National Pressure Injury Advisory Panel (NPIAP) language.
Stage 1: Intact skin with non-blanchable erythema. On darker skin, look for color change, warmth, firmness, or pain rather than redness alone.
Stage 2: Partial-thickness loss with viable pink or red dermis, or a serum-filled blister. No slough, no granulation, no adipose. Moisture-associated skin damage, medical adhesive injury, and skin tears are not automatically stage 2.
Stage 3: Full-thickness loss with visible adipose; slough or eschar may be present; fascia, muscle, and bone are not exposed.
Stage 4: Full-thickness loss with exposed fascia, muscle, tendon, ligament, cartilage, or bone.
Unstageable: The base is hidden by slough or eschar; do not guess a number. Stable, dry heel eschar may be left as a biologic cover when that matches goals.
Deep tissue pressure injury: Persistent non-blanchable deep red, maroon, or purple discoloration; it may evolve quickly.
Do not reverse-stage . A healing full-thickness wound remains a healing stage 3 or 4. Prevention still belongs in hospice when it matches comfort: a support surface, heel offloading, moisture control, and turning the patient will tolerate. Cachexia and hypoperfusion mean extra calories on a tray will not heal every wound. Document what you offered and what the patient declined.
SCALE changes and the Kennedy terminal ulcer
The Skin Changes At Life's End (SCALE) consensus describes hypoperfusion of the skin as other organs fail. Some injuries are unavoidable even when turning, surfaces, and moisture care were appropriate. That is not a license to stop all prevention. It is a license to stop treating every sacral color change as proof of poor nursing.
The Kennedy terminal ulcer is sudden terminal ulceration, often pear-shaped, butterfly-shaped, or horseshoe-shaped over the sacrum, appearing red, yellow, or black days to weeks before death. Describe it carefully as terminal ulceration , a marker of dying physiology. It is not automatically a quality failure . Continue gentle, goal-concordant positioning. Document onset, shape, color, and the prevention already in place. Do not reflexively escalate to a hospital wound vacuum, surgical debridement, or a neglect narrative when the clinical picture is terminal skin failure and the family needed explanation, not blame.
Malignant fungating wounds
A growing tumor will not granulate closed. Agree the goal with the patient and family: odor, exudate, bleeding, pain, and being presentable for visitors — not complete healing. Anaerobic odor responds to topical metronidazole (gel, or crushed tablets in a carrier) and charcoal dressings . Change dressings before they saturate. Use nonadherent layers on friable tumor. For bleeding, use local pressure, alginate, topical hemostatics, and sometimes palliative radiation. Do not wet-to-dry a bleeding tumor to chase a clean bed. Silver dressings and honey products appear in some protocols; they are adjuncts, not a reason to ignore metronidazole when odor is the complaint.
Mouth, mucosa, and itch
Xerostomia follows opioids, anticholinergics, oxygen, radiation, and mouth breathing. Alcohol rinses worsen it. Use saliva substitutes, frequent sips, ice chips if the swallow is safe, sugar-free gum or pilocarpine when glands can still work, a humidifier, and a medication review.
Candidiasis produces plaques that scrape, unlike leukoplakia. Angular cheilitis and an erythematous tongue still count. Nystatin suspension is reasonable for limited oral disease. Fluconazole is the better pick when disease is extensive, esophageal (odynophagia, retrosternal pain), or nystatin has failed.
Mucositis needs bland saline or bicarbonate rinses, a soft brush, infection treatment, topical anesthetic before meals, and no alcohol rinses. Neutropenic mucositis in hospice is a comfort and bleeding problem, not an automatic hospital transfer.
Pruritus is mechanism-based. Antihistamines disappoint when the pathway is not histamine. Uremic itch: emollients plus gabapentin or pregabalin; dialysis only if goals include it. Cholestatic itch: emollients, sertraline, rifampin, or naltrexone in selected patients; bile-acid binders help only if bile reaches the intestine. Opioid itch: rotate the opioid; antihistamines may sedate without relieving neuraxial-type itch.
Wound-goal table: heal versus contain odor and exudate
Situation Primary goal Typical CHPN actions What not to do
Pressure injury in a patient who still turns, eats, and has weeks to months Heal if perfusion and goals allow Offload, moisture balance, treat infection, support surfaces Reverse-stage; ignore offloading
Kennedy / SCALE terminal ulcer in active dying Comfort and honest documentation, not closure Gentle positioning the patient tolerates; protect from shear; explain to family Treat as automatic neglect or force aggressive debridement
Fungating malignant wound Contain odor, exudate, bleeding, appearance Topical metronidazole, charcoal dressings, nonadherent layers, hemostasis, palliative radiation if bleeding Wet-to-dry debridement for healing
Xerostomia, mucositis, or thrush Comfort, swallow, speech Alcohol-free substitutes and rinses; nystatin or fluconazole Alcohol mouthwash to clean the mouth
Pruritus from uremia, cholestasis, or opioids Mechanism-based relief Emollients; gabapentin; opioid rotation; selected cholestasis drugs Diphenhydramine as the only plan
Exam stems often pair a family accusation of poor turning with a pear-shaped sacral wound that appeared over a day or two. Name SCALE or a Kennedy terminal ulcer, continue gentle prevention, and do not convert the case into a quality-failure story. Other stems offer a malodorous chest-wall wound; topical metronidazole plus odor-adsorbing dressings beats systemic vancomycin or scheduled wet-to-dry packing.